Usefulness of Delayed Enhancement Magnetic Resonance Imaging to Differentiate Dilated Phase of Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy

Journal of Cardiac Failure

Volumn 13, Issue 5, 2007, Pages 372-379

  Matoh, Fumitaka ^a   Satoh, Hiroshi ^b   Shiraki, Katsunori ^b   Saitoh, Takeji ^b   Urushida, Tsuyoshi ^b   Katoh, Hideki ^b   Takehara, Yasuo ^c   Sakahara, Harumi ^c   Hayashi, Hideharu ^b  

^a Department of Emergency Medicine ^*

^b Division of Cardiology

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

delayed enhancement; dilated cardiomyopathy; hypertrophic cardiomyopathy; MRI

Indexed keywords

GADOVERSETAMIDE;

ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART MUSCLE INJURY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; SYSTOLE;

ADULT; AGED; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; OBSERVER VARIATION; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 34250888087     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.02.001     Document Type: Article

References (31)

1. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
2. Harris K.M., Spirito P., Maron M.S., Zenovich A.G., Formisano F., Lesser J.R., et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 114 (2006) 216-225
3. Varnava A.M., Elliott P.M., Baboonian C., Davison F., Davies M.J., and McKenna W.J. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation 104 (2001) 1380-1384
4. Spirito P., Seidman C.E., McKenna W.J., and Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med 336 (1997) 775-785
5. Gerber B.L., Garot J., Bluemke D.A., Wu K.C., and Lima J.A.C. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 106 (2002) 1083-1089
6. van Hoe L., and Vanderheyden M. Ischemic cardiomyopathy: value of different MRI techniques for prediction of functional recovery after revascularization. Am J Roentgenol 182 (2004) 95-100
7. Wagner A., Mahrholdt H., Holly T.A., Elliot M.D., Regenfus M., Parker M., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361 (2003) 374-379
8. Matoh F., Hayashi H., Terada H., Satoh H., Katoh H., Urushida T., et al. Usefulness of delayed enhancement magnetic resonance imaging for detecting cardiac rupture caused by small myocardial infarction in a case of cardiac tamponade. Circ J 69 (2005) 1556-1559
9. Wilson J.M., Villareal R.P., Hariharan R., Massumi A., Muthupillai R., and Flamm S.D. Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. Tex Heart Inst J 29 (2002) 176-180
10. Bogaert J., Goldstein M., Tannouri F., Golzarian J., and Dymarkowski S. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging. Am J Roentgenol 180 (2003) 981-985
11. Teraoka K., Hirano M., Ookubo H., Sasaki K., Katsuyama H., Amino M., et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 22 (2004) 155-161
12. Amano Y., Takayama M., Takahama K., and Kumazaki T. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances. J Magn Reson Imaging 20 (2004) 595-600
13. Matsunaka T., Hamada M., Matsumoto Y., and Higaki J. First-pass myocardial perfusion defect and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with MRI. Magn Reson Med Sci 2 (2003) 61-69
14. Moon J.C.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennel D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
15. Knaapen P., van Dockum W.G., Bondarenko O., Kok W.E., Gotte M.J., Boellaard R., et al. Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. J Nucl Med 46 (2005) 923-929
16. Koito H., Suzuki J., Ohkubo N., Ishiguro Y., Iwasaki T., and Inada M. Gadolinium-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging of dilated cardiomyopathy: clinical significance of abnormally high signal intensity of left ventricular myocardium. J Cardiol 28 (1996) 41-49
17. Akisawa M., Matsumura Y., Kitaoka H., Yamasaki N., Takata J., and Doi Y. Myocardial enhancement on magnetic resonance imaging with gadolinium-diethylenetriamine pentaacetic acid and improvement of left ventricular function in patients with dilated cardiomyopathy. J Cardiol 40 (2002) 145-152
18. McCrohon J.A., Moon J.C., Prasad S.K., McKenna W.J., Lorenz C.H., Coats A.J., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108 (2003) 54-59
19. Zimmermann O., Grebe O., Merkle N., Nusser T., Kochs M., Bienek-Ziolkowski M., et al. Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy. Eur J Heart Fail 8 (2006) 162-166
20. Richardson C., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 93 (1996) 841-842
21. Berman D.S., Kiat H., Friedman J.D., Wang F.P., van Train K., Matzer L., et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 22 (1993) 1455-1464
22. Edelman R.R. Contrast-enhanced MR imaging of the heart: overview of the literature. Radiology 232 (2004) 653-668
23. Debl K., Djavidani B., Buchner S., Lipke C., Nitz W., Feuerbach S., et al. Delayed hyperenhancement: frequent finding in magnetic resonance imaging of left ventricular hypertrophy due to aortic stenosis and hypertrophic cardiomyopathy. Heart 92 (2006) 1447-1451
24. Kuribayashi T., and Roberts W.C. Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol 70 (1992) 1333-1340
25. Yutani C., Imakita M., Ishibashi-Ueda H., Hatanaka K., Nagata S., Sakakibara H., et al. Three autopsy cases of progression to left ventricular dilation in patients with hypertrophic cardiomyopathy. Am Heart J 109 (1985) 545-553
26. Iida K., Yutani C., Imakita M., and Ishibashi-Ueda H. Comparison of percentage area of myocardial fibrosis and disarray in patients with classical form and dilated phase of hypertrophic cardiomyopathy. J Cardiol 32 (1998) 173-180
27. Moon J.C.C., Emma R., Sheppard M.N., Elkington A.G., Ho S.Y., Burke M., et al. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43 (2004) 2260-2264
28. Chien K.R. Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies. J Clinical Invest 111 (2003) 175-178
29. Rickers C., Wilke N.M., Jerosch-Herold M., Casey S.A., Panse P., Panse N., et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112 (2005) 855-861
30. Moon J.C.C., Fisher N.G., McKenna W.J., and Pennell D.J. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90 (2004) 645-649
31. Tseng W.Y., Dou J., Reese T.G., and Wedeen V.J. Imaging myocardial fiber disarray and intramural strain hypokinesis in hypertrophic cardiomyopathy with MRI. J Magn Reson Imaging 23 (2006) 1-8